MOTS-C: The Mitochondrial-Derived Peptide and What It Does to Your Metabolism
MOTS-C is a peptide encoded within the mitochondrial genome — a metabolic regulator that translates cellular energy status into broader systemic signals. Its discovery has been described as a paradigm shift in understanding how mitochondria communicate with the rest of the body.
By UAE Peptide Clinic Research Desk
MOTS-C is a peptide encoded within the mitochondrial genome — specifically within the 12S rRNA gene. It is one of a small family of mitochondrial-derived peptides that act as metabolic regulators, translating information about the cell's energy status into broader systemic signals. Its discovery has been described as a paradigm shift in understanding how mitochondria communicate with the rest of the body.
Mechanism of Action
MOTS-C acts primarily through AMPK (AMP-activated protein kinase) activation — a central regulator of cellular energy metabolism. It promotes glucose uptake into muscle cells, suppresses fatty acid synthesis, and supports insulin sensitivity. In animal models, MOTS-C administration has increased exercise capacity, reversed age-related metabolic decline, and extended healthy lifespan. Circulating MOTS-C levels decline measurably with age in humans.
Clinical Applications
MOTS-C is used in physician-supervised protocols targeting metabolic health, age-related energy decline, exercise capacity, and longevity. It is particularly relevant for patients showing signs of metabolic syndrome, insulin resistance, or the energy decline typically associated with advancing age.
- Available formats: Vial 10mg, Pen 15mg
- Targets AMPK pathway — the central metabolic energy sensor
- Circulating levels decline measurably with age
- Relevant for metabolic syndrome, insulin resistance, energy decline
MOTS-C represents a new frontier in longevity medicine. Our physicians will review your metabolic panel before determining whether it belongs in your protocol. Explore it at /peptides/mots-c or book a consultation at /book.